Loading...

JMS Co.,Ltd.

7702.TJPX
Healthcare
Medical - Instruments & Supplies
¥425.00
¥-1.00(-0.23%)
Japanese Market opens in 55h 2m

JMS Co.,Ltd. Fundamental Analysis

JMS Co.,Ltd. (7702.T) shows moderate financial fundamentals with a PE ratio of -46.76, profit margin of -0.34%, and ROE of -0.55%. The company generates $66.1B in annual revenue with moderate year-over-year growth of 6.83%.

Key Strengths

Cash Position99.85%
PEG Ratio-0.06
Current Ratio1.83

Areas of Concern

ROE-0.55%
Operating Margin0.37%
We analyze 7702.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 28.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
28.7/100

We analyze 7702.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

7702.T struggles to generate sufficient returns from assets.

ROA > 10%
-0.26%

Valuation Score

Excellent

7702.T trades at attractive valuation levels.

PE < 25
-46.76
PEG Ratio < 2
-0.06

Growth Score

Moderate

7702.T shows steady but slowing expansion.

Revenue Growth > 5%
6.83%
EPS Growth > 10%
3.47%

Financial Health Score

Excellent

7702.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.65
Current Ratio > 1
1.83

Profitability Score

Weak

7702.T struggles to sustain strong margins.

ROE > 15%
-54.90%
Net Margin ≥ 15%
-0.34%
Positive Free Cash Flow
No

Key Financial Metrics

Is 7702.T Expensive or Cheap?

P/E Ratio

7702.T trades at -46.76 times earnings. This suggests potential undervaluation.

-46.76

PEG Ratio

When adjusting for growth, 7702.T's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values JMS Co.,Ltd. at 0.25 times its book value. This may indicate undervaluation.

0.25

EV/EBITDA

Enterprise value stands at -1.44 times EBITDA. This is generally considered low.

-1.44

How Well Does 7702.T Make Money?

Net Profit Margin

For every $100 in sales, JMS Co.,Ltd. keeps $-0.34 as profit after all expenses.

-0.34%

Operating Margin

Core operations generate 0.37 in profit for every $100 in revenue, before interest and taxes.

0.37%

ROE

Management delivers $-0.55 in profit for every $100 of shareholder equity.

-0.55%

ROA

JMS Co.,Ltd. generates $-0.26 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.26%

Following the Money - Real Cash Generation

Operating Cash Flow

JMS Co.,Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

JMS Co.,Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

7702.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-46.76

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.25

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.16

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.65

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.83

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.01

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.004

vs 25 benchmark

How 7702.T Stacks Against Its Sector Peers

Metric7702.T ValueSector AveragePerformance
P/E Ratio-46.7629.43 Better (Cheaper)
ROE-0.55%698.00% Weak
Net Margin-0.34%-46280.00% (disorted) Weak
Debt/Equity0.650.42 Weak (High Leverage)
Current Ratio1.834.50 Neutral
ROA-0.26%-14638.00% (disorted) Weak

7702.T outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews JMS Co.,Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

18.53%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-95.52%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-59.04%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ